News Releases

Best of EAU24 Abstracts – SonoMotion’s Break Wave First-In-Human clinical results to be featured at the EAU24 plenary session “Best of EAU24 Abstracts: An expert discussion” on Monday, April 8, 2024.

Strong presence at the European Association of Urology conference with two Break Wave presentations, including (i) First-In-Human clinical trial results by Dr. Ben Chew and (ii) “Advances in technology – Burst-wave lithotripsy: All set?” by Dr. Mehmet Özsoy.

SonoMotion initiates Break Wave pivotal trial (SOUND) at ten sites in the United States and Canada.

SonoMotion receives FDA Breakthrough Device Designation for Break Wave™ procedure.

Sonomotion raises USD$12.4 Million in Series C funding to advance development of Break Wave™. Round co-led by UWH LLC and Advance MedTech Holdings Pte. Ltd.

Come visit SonoMotion at the American Urological Association conference in New Orleans on May 13-15 (Booth #1909).

First of its kind procedure successfully conducted by SonoMotion and Vancouver Aquarium on Hermes, a harbor seal suffering from kidney stones (press release and video).

Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release).